Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.
Financial Results:
Ipca Laboratories Ltd reported Revenues for Q1FY25 of ₹2,093.00 Crores up from ₹1,585.00 Crore year on year, a rise of 32.05%.
Total Expenses for Q1FY25 of ₹1,823.00 Crores up from ₹1,378.00 Crores year on year, a rise of 32.29%.
Consolidated Net Profit of ₹199.00 Crores up 21.34% from ₹164.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹7.58, up 18.07% from ₹6.42 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.